EUR 0.19
(-3.02%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 361.68 Million EUR | -3.73% |
2022 | 375.69 Million EUR | -7.05% |
2021 | 404.2 Million EUR | -3.62% |
2020 | 419.37 Million EUR | -48.89% |
2019 | 820.57 Million EUR | 6.1% |
2018 | 773.36 Million EUR | -7.73% |
2017 | 838.1 Million EUR | 3.61% |
2016 | 808.91 Million EUR | -10.86% |
2015 | 907.51 Million EUR | -4.11% |
2014 | 946.4 Million EUR | -13.85% |
2013 | 1.09 Billion EUR | -0.69% |
2012 | 1.1 Billion EUR | -5.79% |
2011 | 1.17 Billion EUR | -20.06% |
2010 | 1.46 Billion EUR | -26.99% |
2009 | 2.01 Billion EUR | -16.34% |
2008 | 2.4 Billion EUR | 108.56% |
2007 | 1.15 Billion EUR | 0.99% |
2006 | 1.14 Billion EUR | 44.62% |
2005 | 789.53 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 Q3 | - EUR | -100.0% |
2023 Q4 | 361.68 Million EUR | 0.0% |
2023 Q1 | - EUR | -100.0% |
2023 FY | 361.68 Million EUR | -3.73% |
2023 Q2 | 378.23 Million EUR | 0.0% |
2022 FY | 375.69 Million EUR | -7.05% |
2022 Q4 | 375.69 Million EUR | 0.0% |
2022 Q3 | - EUR | -100.0% |
2022 Q2 | 389.9 Million EUR | 0.0% |
2021 Q2 | 396.68 Million EUR | -9.99% |
2021 Q3 | 409.44 Million EUR | 3.22% |
2021 FY | 404.2 Million EUR | -3.62% |
2021 Q1 | 440.69 Million EUR | 5.08% |
2021 Q4 | 404.2 Million EUR | -1.28% |
2020 Q2 | 462.18 Million EUR | -44.48% |
2020 Q1 | 832.53 Million EUR | 1.46% |
2020 Q4 | 419.37 Million EUR | -8.72% |
2020 FY | 419.37 Million EUR | -48.89% |
2020 Q3 | 459.46 Million EUR | -0.59% |
2019 Q1 | 804.8 Million EUR | 4.07% |
2019 FY | 820.57 Million EUR | 6.1% |
2019 Q3 | 810.72 Million EUR | 1.21% |
2019 Q4 | 820.57 Million EUR | 1.22% |
2019 Q2 | 801 Million EUR | -0.47% |
2018 Q2 | 833.07 Million EUR | -0.58% |
2018 FY | 773.36 Million EUR | -7.73% |
2018 Q4 | 773.36 Million EUR | -6.87% |
2018 Q3 | 830.4 Million EUR | -0.32% |
2018 Q1 | 837.97 Million EUR | -0.02% |
2017 Q3 | 830.93 Million EUR | 0.0% |
2017 FY | 838.1 Million EUR | 3.61% |
2017 Q4 | 838.1 Million EUR | 0.86% |
2016 Q4 | 808.91 Million EUR | 0.0% |
2016 FY | 808.91 Million EUR | -10.86% |
2015 Q2 | 949.83 Million EUR | 0.0% |
2015 FY | 907.51 Million EUR | -4.11% |
2015 Q4 | 907.51 Million EUR | 0.0% |
2014 Q2 | 985.32 Million EUR | 0.0% |
2014 Q4 | 946.4 Million EUR | 0.0% |
2014 FY | 946.4 Million EUR | -13.85% |
2013 Q2 | 1.05 Billion EUR | 0.0% |
2013 FY | 1.09 Billion EUR | -0.69% |
2013 Q4 | 1.09 Billion EUR | 0.0% |
2012 Q4 | 1.1 Billion EUR | 0.0% |
2012 Q2 | 1.11 Billion EUR | 0.0% |
2012 FY | 1.1 Billion EUR | -5.79% |
2011 Q4 | 1.17 Billion EUR | 0.0% |
2011 FY | 1.17 Billion EUR | -20.06% |
2011 Q2 | 1.35 Billion EUR | 0.0% |
2010 Q4 | 1.46 Billion EUR | 0.0% |
2010 FY | 1.46 Billion EUR | -26.99% |
2010 Q2 | 1.94 Billion EUR | 0.0% |
2009 Q4 | 2.01 Billion EUR | 0.0% |
2009 FY | 2.01 Billion EUR | -16.34% |
2008 FY | 2.4 Billion EUR | 108.56% |
2007 FY | 1.15 Billion EUR | 0.99% |
2006 FY | 1.14 Billion EUR | 44.62% |
2005 FY | 789.53 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Ebro Foods, S.A. | 1.64 Billion EUR | 78.072% |
Naturhouse Health, S.A. | 18.21 Million EUR | -1885.851% |